| PRECLINICAL | evidence | Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats. | BPC 157 | — | 2019-07-02 |
| PRECLINICAL | evidence | Cytoprotective Mechanism of the Novel Gastric Peptide BPC157 in Gastrointestinal Tract and Cultured Enteric Neurons and Glial Cells. | BPC 157 | Gut barrier & GI healing | 2019-02-01 |
| PRECLINICAL | evidence | Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine. | BPC 157 | — | 2018-12-21 |
| PRECLINICAL | evidence | Engineering recombinant Lactococcus lactis as a delivery vehicle for BPC-157 peptide with antioxidant activities. | BPC 157 | preclinical | 2018-12-01 |
| PRECLINICAL | evidence | BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing. | BPC 157 | Gut barrier & GI healing | 2018-01-01 |
| PRECLINICAL | evidence | Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract Healing. | BPC 157 | Gut barrier & GI healing | 2018-01-01 |
| PRECLINICAL | evidence | BPC157 as Potential Agent Rescuing from Cancer Cachexia. | BPC 157 | — | 2018-01-01 |
| PRECLINICAL | evidence | Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H. | BPC 157 | Growth hormone axis | 2017-10-01 |
| PRECLINICAL | evidence | Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME. | BPC 157 | Gut barrier & GI healing | 2017-08-07 |
| PRECLINICAL | evidence | Hypermagnesemia disturbances in rats, NO-related: pentadecapeptide BPC 157 abrogates, L-NAME and L-arginine worsen. | BPC 157 | Gut barrier & GI healing | 2017-08-01 |
| PRECLINICAL | evidence | Class side effects: decreased pressure in the lower oesophageal and the pyloric sphincters after the administration of dopamine antagonists, neuroleptics, anti-emetics, L-NAME, pentadecapeptide BPC 157 and L-arginine. | BPC 157 | — | 2017-05-17 |
| PRECLINICAL | evidence | Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. | BPC 157 | — | 2017-03-01 |
| PRECLINICAL | evidence | Stress in Gastrointestinal Tract and Stable Gastric Pentadecapeptide BPC 157. Finally, do we have a Solution? | BPC 157 | — | 2017-01-01 |
| PRECLINICAL | evidence | "Stress" is 80 Years Old: From Hans Selye Original Paper in 1936 to Recent Advances in GI Ulceration. | BPC 157 | Gut barrier & GI healing | 2017-01-01 |
| PRECLINICAL | evidence | Stable gastric pentadecapeptide BPC 157 and bupivacaine. | BPC 157 | — | 2016-12-15 |
| PRECLINICAL | evidence | Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. | BPC 157 | Gut barrier & GI healing | 2016-01-01 |
| PRECLINICAL | evidence | Stable gastric pentadecapeptide BPC 157-NO-system relation. | BPC 157 | — | 2014-01-01 |
| PRECLINICAL | evidence | BPC 157 and blood vessels. | BPC 157 | Wound healing | 2014-01-01 |
| PRECLINICAL | evidence | Mortal hyperkalemia disturbances in rats are NO-system related. The life saving effect of pentadecapeptide BPC 157. | BPC 157 | — | 2013-02-10 |
| PRECLINICAL | evidence | Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157. | BPC 157 | Gut barrier & GI healing | 2013-01-01 |
| PRECLINICAL | evidence | Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157. | BPC 157 | Gut barrier & GI healing | 2012-01-01 |
| PRECLINICAL | evidence | BPC 157 therapy to detriment sphincters failure-esophagitis-pancreatitis in rat and acute pancreatitis patients low sphincters pressure. | BPC 157 | Gut barrier & GI healing | 2011-10-01 |
| PRECLINICAL | evidence | The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. | BPC 157 | Tendon & ligament repair · preclinical | 2011-03-01 |
| PRECLINICAL | evidence | Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. | BPC 157 | Gut barrier & GI healing | 2011-01-01 |
| PRECLINICAL | evidence | Revised Robert's cytoprotection and adaptive cytoprotection and stable gastric pentadecapeptide BPC 157. Possible significance and implications for novel mediator. | BPC 157 | Gut barrier & GI healing | 2010-01-01 |
| PRECLINICAL | evidence | Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing. | BPC 157 | — | 2009-12-01 |
| PRECLINICAL | evidence | Enhancement by PL 14736 of granulation and collagen organization in healing wounds and the potential role of egr-1 expression. | BPC 157 | — | 2007-09-10 |
| PRECLINICAL | evidence | Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and vascular response. | BPC 157 | Gut barrier & GI healing | 2006-12-01 |
| PRECLINICAL | evidence | The pharmacological properties of the novel peptide BPC 157 (PL-10). | BPC 157 | — | 1999-01-01 |
| PRECLINICAL | evidence | Some aspects of the effects of PL-10.1.AK-15 on the gastrointestinal tract. | BPC 157 | Gut barrier & GI healing | 1997-05-01 |
| PRECLINICAL | evidence | Evidence for direct cellular protective effect of PL-10 substances (synthesized parts of body protection compound, BPC) and their specificity to gastric mucosal cells. | BPC 157 | — | 1997-01-01 |
| PRECLINICAL | evidence | A new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC. | BPC 157 | Inflammation | 1993-01-01 |
| INDEPENDENT-REVIEW | review | Is bpc-157 the best peptide for physical therapy and recovery?
Pretty straightforward question, what is the best peptide for physical therapy and recovery?
I’ve heard that peptides like tb-500 and cjc can be effective, but which one is the best?
I don’t have the budget to buy that combination of the three, wolverine stack or something similar, which is why I’m looking for a single compound. | COMMUNITY | — | 2026-07-26 |
| INDEPENDENT-REVIEW | review | What is a reasonable price for bpc-157?
To preface, I do not want source recommendations.
What I need is a general price estimate for how much high quality tested peptides should cost while buying from a US based company. I’m aware I can get them cheaper from Telegram or some Chinese lab, but the convenience is worth the cost for me. | COMMUNITY | — | 2026-07-26 |
| INDEPENDENT-REVIEW | review | My experience with BPC-157: good effects at first, then a bad reaction
I’m a 48-year-old man, around 180 cm and 85 kg. I live quite healthily, exercise regularly, don’t smoke and don’t drink alcohol. I’ve also never had allergic reactions to medication, supplements or vaccines. Over the years I’ve taken many different supplements, several vaccines for travel in Africa and malaria medication | COMMUNITY | — | 2026-07-26 |
| INDEPENDENT-REVIEW | review | Anyone used BPC-157 for Frozen Shoulder?
Basically no solutions to this than time right now. Can't train my way out of it like tendonitis or low back rehab. Doc says just wait it out and can't load hard until then.
Anyone used BPC for this? Its a real tough one. | COMMUNITY | — | 2026-07-26 |
| INDEPENDENT-REVIEW | review | BPC-157 & TB-500 | COMMUNITY | — | 2026-07-24 |
| INDEPENDENT-REVIEW | review | Experiences with BPC-157, TB-500 and/or ARA-290 for L4/L5 & L5/S1 disc herniation
[removed] | COMMUNITY | — | 2026-07-23 |
| INDEPENDENT-REVIEW | review | FDA panel votes to place popular peptide BPC-157 on compounding list | COMMUNITY | — | 2026-07-23 |
| INDEPENDENT-REVIEW | review | BPC-157 + TB-500
[removed] | COMMUNITY | — | 2026-07-23 |
| INDEPENDENT-REVIEW | review | BPC- 157 | TB-500 Questions
[removed] | COMMUNITY | — | 2026-07-22 |
| INDEPENDENT-REVIEW | review | BPC-157 + TB-500 for meniscus surgery recovery — dosage, reconstitution
[removed] | COMMUNITY | — | 2026-07-22 |
| INDEPENDENT-REVIEW | review | BPC-157 + TB-500 for meniscus surgery recovery — dosage, reconstitution, and source recommendations?
[removed] | COMMUNITY | — | 2026-07-22 |
| INDEPENDENT-REVIEW | review | FDA advisory committee is voting on BPC-157, TB-500, Semax, Epitalon and 3 others starting tomorrow
[removed] | COMMUNITY | — | 2026-07-22 |
| INDEPENDENT-REVIEW | review | BPC-157/TB-4 Blend – Reconstitution/Dosing
I separated my shoulder and plan to use a BPC/TB blend to hopefully aid recovery while I'm doing physical therapy in the coming months. I've never taken peptides before, so I wanted to triple check and see if anyone can confirm I have the reconstitution and dosing correct. Beyond the math, if there are any recommendations to the cycle length or amount | COMMUNITY | — | 2026-07-22 |
| INDEPENDENT-REVIEW | review | BPC-157 tablets work?
[removed] | COMMUNITY | — | 2026-07-21 |
| INDEPENDENT-REVIEW | review | Pharmalabglobal BPC-157 Tablets (oral) legitimacy
[removed] | COMMUNITY | — | 2026-07-21 |
| INDEPENDENT-REVIEW | review | could BPC-157 and TB500 help my dad ?
So my father has always worked in jobs that can be tough on the body, he always complains about back pain and stiffness, if anyone has the same issue but tried these compounds, please tell me about your experience and tell me if it’s worth the money. thanks in advance | COMMUNITY | — | 2026-07-21 |
| INDEPENDENT-REVIEW | review | Has anyone else experienced night sweats from BPC-157?
Every time I start taking BPC-157, I wake up absolutely soaked in sweat during the night. If I stop taking it, the night sweats disappear. If I start it again, they come right back. I’ve repeated this cycle multiple times, so it seems pretty clear there’s a connection.
I’m curious if anyone else has experienced this or has any idea why it | COMMUNITY | — | 2026-07-18 |
| INDEPENDENT-REVIEW | review | Advice Tesamorelin, Ipamorelin, BPC-157, TB-500
[removed] | COMMUNITY | — | 2026-07-16 |